The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Poly(4-Hydroxybutyrate): Current State and Perspectives
Open accessAbstract
By the end of 1980s, for the first time polyhydroxyalkanoate (PHA) copolymers with incorporated 4-hydroxybutyrate (4HB) units were produced in the bacterium Cupriavidus necator (formally Ralstonia eutropha) from structurally related carbon sources. After that, production of PHA copolymers composed of 3-hydroxybutyrate (3HB) and 4HB [P(3HB-co-4HB)] was demonstrated in diverse wild-type bacteria. The P4HB homopolymer, however, was hardly synthesized because existing bacterial metabolism on 4HB precursors also generate and incorporate 3HB. The resulting material assumes the properties of thermoplastics and elastomers depending on the 4HB fraction in the copolyester. Given the fact that P4HB is biodegradable and yield 4HB, which is a normal compound in the human body and proven to be biocompatible, P4HB has become a prospective material for medical applications, which is the only FDA approved PHA for medical applications since 2007. Different from other materials used in similar applications, high molecular weight P4HB cannot be produced via chemical synthesis. Thus, aiming at the commercial production of this type of PHAs, genetic engineering was extensively applied resulting in various production strains, with the ability to convert unrelated carbon sources (e.g. sugars) to 4HB, and capable of producing homopolymeric P4HB. In 2001, Metabolix Inc. filed a patent concerning genetically modified and stable organisms, e.g., Escherichia coli, producing P4HB and copolymers from inexpensive carbon sources. The patent is currently hold by Tepha Inc., the only worldwide producer of commercial P4HB. To date, numerous patents on various applications of P4HB in the medical field have been filed. This review will comprehensively cover the historical evolution and the most recent publications on P4HB biosynthesis, material properties, and industrial and medical applications. Finally, perspectives for the research and commercialization of P4HB will be presented.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacterial Polyesters: Biosynthesis, Biodegradable Plastics and Biotechnology
Lenz, R. W., & Marchessault, R. H. (2005) · Biomacromolecules · doi:10.1021/bm049700c · Cited by 780
Doi, Y., Kanesawa, Y., Kunioka, M., & Saito, T. (1990) · Macromolecules · doi:10.1021/ma00203a006 · Cited by 515
Furrer, P., Panke, S., & Zinn, M. (2007) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2007.01.002 · Cited by 76
Self-citation
Cited by
Bioplastics for a circular economy
Rosenboom, J.-G., Langer, R., & Traverso, G. (2022) · Nature Reviews Materials · doi:10.1038/s41578-021-00407-8 · Cited by 2,116
McAdam, B., Brennan Fournet, M., McDonald, P., & Mojicevic, M. (2020) · Polymers · doi:10.3390/polym12122908 · Cited by 568
Metadata
- Authors
- Utsunomia, C., Ren, Q., & Zinn, M.
- Venue
- Frontiers in Bioengineering and Biotechnology
- Publisher
- Frontiers Media SA
- Published
- 2020-04-03
- Volume
- 8
- Pages
- 257-257
- ISSN
- 2296-4185 (ISSN-L)
- OpenAlex
- W3014829492
- Cited by
- 162
- References
- 3
- FWCI
- 4.76
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Poly(4-Hydroxybutyrate): Current State and Perspectives. https://app.cochat.ai/papers/10.3389/fbioe.2020.00257
- The paper
- Utsunomia, C., Ren, Q., & Zinn, M. (2020). Poly(4-Hydroxybutyrate): Current State and Perspectives. Frontiers in Bioengineering and Biotechnology. https://doi.org/10.3389/fbioe.2020.00257
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.